FLUQUADRI

Nazione: Indonesia

Lingua: indonesiano

Fonte: Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

Principio attivo:

A/BRISBANE/02/2018 (H1N1) PDM09 LIKE VIRUS, A/KANSAS/14/2017 (H3N2) LIKE VIRUS (A/KANSAS/14/2017, X-327), B/COLORADO/06/2017-LIKE VIRUS (B/MARYLAND/15/2016, BX-69A (VICTORIA LINEAGE)), B/PHUKET/3073/2013-LIKE VIRUS (B/YAMAGATA/16/88 LINEAGE)

Commercializzato da:

AVENTIS PHARMA - Indonesia

INN (Nome Internazionale):

A/BRISBANE/02/2018 (H1N1) PDM09 LIKE VIRUS, A/KANSAS/14/2017 (H3N2) LIKE VIRUS (A/KANSAS/14/2017, X-327), B/COLORADO/06/2017-LIKE VIRUS (B/MARYLAND/15/2016, BX-69A (VICTORIA LINEAGE)), B/PHUKET/3073/2013-LIKE VIRUS (B/YAMAGATA/16/88 LINEAGE)

Dosaggio:

15 MCG /15 MCG /15 MCG /15 MCG

Forma farmaceutica:

SUSPENSI INJEKSI

Confezione:

DUS, 5 SYRINGE @ 0,5 ML ( 1 DOSIS)

Prodotto da:

SANOFI PASTEUR, INC - United States of America

Data dell'autorizzazione:

2021-06-19

Scheda tecnica

DISETUJUI OLEH BPOM : 14/08/2019
ID EREG100022VR11900175
DISETUJUI OLEH BPOM : 14/08/2019
ID EREG100022VR11900175
DISETUJUI OLEH BPOM : 14/08/2019
ID EREG100022VR11900175
DISETUJUI OLEH BPOM : 14/08/2019
ID EREG100022VR11900175